-
For many patients with moderate- severe chronic obstructive pulmonary disease, acute exacerbations (AECOPD) are highly problematic.
-
Both urgency and bladder pain can lead to nocturia in patients with interstitial cystitis.
-
A kinase inhibitor for late-stage melanoma and its companion diagnostic test have been approved by the FDA.
-
The authors conclude that this large observational study suggests ACEI or ARB therapy is associated with an improved survival and a lower risk of cardiovascular events in patients with aortic stenosis.
-
We all know that we should be drinking more green tea; every few days, either the media or medical journals are touting a new use for the Asian staple. Can it really cure breast cancer while preventing liver disease, simultaneously increasing knee range of motion in people suffering from osteroarthritis? The answer is "possibly, yes," but an evidence-based review refines the glowing reports with some clinical pearls, dosing specifics, and hopeful avenues of future research, as detailed below.
-
Participation in Weight Watchers resulted in a greater weight loss over a year than did clinical intervention in a primary care office.
-
Data from this large observational trial with an average follow-up of over 8 years suggest that even 15 minutes a day of moderate-intensity exercise, such as taking a brisk walk, provides significant health benefits in terms of lowered mortality risks and life extension.
-
In a case-control study using a biomarker for lignan intake, women with breast cancer who had higher levels of the biomarker post-diagnosis had a reduced risk of mortality over a median follow-up period of 6 years compared to women with low levels of the biomarker.
-
Thousands of Chinese used a compound called maxingshigan-yinqiaosan (MY) for treatment of flu symptoms during the 2009 H1N1 epidemic. MY is a concoction of 12 different herbs, including toasted Herba ephedra, as well as qinghao, gypsum fibrosum, and rhizoma.
-
The SELECT Trial investigators report on nearly 10 years of follow-up of participants in a study of selenium and vitamin E and the risk of prostate cancer. A small but statistically significant increased risk of prostate cancer appears to be associated with taking vitamin E supplements. These results are in disagreement with others in the literature, and the authors present no plausible biological explanation for them. Nonetheless, the balance of evidence does not appear to support any recommendation that physicians advise their middle-aged and elderly patients to begin vitamin E supplementation for prostate cancer prevention.
